In 2025, the FDAAA 801 Final Rule introduces tighter timelines, new standardized data fields, stronger reporting compliance, and enhanced penalties for non-compliance on ClinicalTrials.gov. Sponsors, CROs, and investigators must adapt by updating SOPs, auditing data, and meeting faster reporting deadlines.…
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.